An example of overexpression of an miRNA in type 2 diabetes is miR-200c, which decreases the expression of ETS variant transcription factor 5 (ETV5), causing disruption to insulin exocytosis
Ready to Try Semaglutide for Weight Loss in Mesa, AZ
Obes Surg 2014
Whatever stage retatrutide reaches in development, a dual-action treatment that is licensed and available in the UK today is Mounjaro (tirzepatide) injections, which a registered prescriber can assess for suitability
Front Endocrinol (Lausanne) 14:1185221 Rentzeperi E, Pegiou S, Koufakis T et al (2022) Sex differences in response to treatment with Glucagon-like peptide 1 receptor agonists: opportunities for a tailored approach to diabetes and obesity care
Key Takeaways Wegovy Pill (oral semaglutide, 25 mg, Novo Nordisk) was FDA-approved for weight loss on December 22nd, 2025 with the medication expected to be available to patients in early January 2026